FTO

FTO rs10852521 — A Secondary Intron Signal for Body Fat Accumulation

The FTO (fat mass and obesity-associated) gene contains one of the most replicated
loci in human obesity genetics. While the primary signal — tagged by
rs9939609 | The most studied FTO variant; explained in the Energy & Weight category
— sits in a regulatory cluster in intron 1 that controls IRX3/IRX5 expression in
preadipocytes, the FTO locus harbors multiple distinct linkage disequilibrium | LD: the
tendency of nearby genetic variants to be inherited together. Variants in the same LD block
are correlated; independent signals are in different LD blocks
blocks spanning the gene. rs10852521 is an intronic FTO variant that tags a separate LD
block with its own — though overlapping — association with body mass index and related
adiposity traits.

The Mechanism

rs10852521 is located in intron 1 of FTO at chromosome 16:53,771,053 (GRCh38). Like
other FTO intron 1 variants, it is not itself a coding mutation — it does not change
any amino acid sequence. Instead, intronic FTO variants influence
FTO primary transcript abundance | Risk alleles increase FTO mRNA levels, shifting the
m6A demethylase toward higher activity.
FTO encodes an N6-methyladenosine (m6A) RNA demethylase | m6A is the most abundant
chemical modification on messenger RNA; FTO removes it, altering mRNA processing,
stability, and translation of target genes.
Through this m6A eraser activity, FTO regulates ghrelin mRNA stability — increased FTO
expression raises circulating ghrelin, the principal hunger hormone, and simultaneously
promotes preadipocyte differentiation toward energy-storing white adipocytes rather than
thermogenic beige adipocytes. Higher FTO transcript levels thus tilt energy balance
toward fat accumulation through two reinforcing routes: increased appetite signaling
and reduced thermogenesis.

The Evidence

The clearest evidence for rs10852521 comes from a multiethnic analysis of FTO variants
| Wing et al. 2011, Insulin Resistance Atherosclerosis Study (IRAS) Family Study cohort
examining 26 FTO SNPs across Hispanic American, African American, and non-Hispanic White
participants. In Hispanic Americans (n=373), rs10852521 showed the most significant
per-SNP BMI association after Bonferroni correction (p=5.2×10⁻⁴). The association was
nominally significant in African Americans (p=4.4×10⁻³) and non-Hispanic Whites
(p=0.048), following the same directional pattern. Notably, the variant falls in a
different LD block from rs9939609 in African-ancestry populations — meaning it tags
partially independent genetic variation, not just the same causal alleles in disguise.

The broader FTO locus biology reinforces this interpretation. Physical activity
attenuates FTO-driven obesity risk | Meta-analysis of 218,166 adults: active individuals
show 27% lower FTO allele effect than sedentary individuals
consistently across FTO variants, reflecting the gene-environment interaction at the
level of the locus rather than any single SNP. Exercise training studies find that FTO
C-allele carriers lose approximately three times more fat mass | Rankinen et al. 2010,
HERITAGE Family Study, 20-week supervised endurance training
than T/T homozygotes in response to structured endurance training — an effect accounting
for roughly 2% of the variance in fat mass change with exercise.

The evidence level for rs10852521 specifically is rated moderate: the association is
replicated across ethnicities and consistent with FTO locus biology, but effect sizes
for this specific variant are less precisely estimated than for the primary rs9939609 /
rs1421085 cluster, and the variant is not yet catalogued in ClinVar or GWAS Catalog
as an independent signal.

Practical Actions

The key finding from exercise studies — that C-allele carriers show disproportionately
larger fat mass reductions from aerobic training — is directly actionable. This variant
suggests that structured endurance training is particularly effective at mobilizing
FTO-associated fat accumulation. The mechanism may involve compensatory upregulation
of thermogenic pathways that counteract the intronic FTO regulatory signal.

Diet composition also matters for FTO carriers: higher-protein diets (25% of calories)
reduce food cravings and improve satiety signaling in FTO risk allele carriers, likely
compensating for reduced GLP-1 and peptide YY responses that contribute to impaired
fullness perception.

Interactions

rs10852521 is in partial linkage disequilibrium with the primary FTO obesity signals
(rs9939609, rs1421085, rs8050136) in European-ancestry populations, but the LD structure
differs in African-ancestry populations — making rs10852521 a more informative independent
tag SNP in those ancestral groups. Users who also carry the rs9939609 A allele (the
primary FTO risk variant) face compounded FTO pathway burden, as both variants increase
FTO transcript levels through potentially distinct regulatory mechanisms in the intron 1
region.